Gan & Lee Pharmaceuticals.

Direct answer

Gan & Lee Pharmaceuticals. is publicly traded on SHH under the ticker 603087.SS.

Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin...

Can you invest in Gan & Lee Pharmaceuticals.?

Yes. Gan & Lee Pharmaceuticals. trades publicly on SHH as 603087.SS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Gan & Lee Pharmaceuticals.

Detailed equity research is provided by MarketSnap.